Amir Jalali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amir Jalali has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ali Salehzadeh
Department of Biology, Ra.C., Islamic Azad University, Rasht, Iran.
6 shared publications Mohadese Farahani
Department of Biology, Faculty of Science, Arak University, Arak, Iran
3 shared publications- Akram Sadat Naeemi
Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran
2 shared publications Bahareh Abbasi
Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran
2 shared publicationsMajid Komijani
Department of Biology, Faculty of Science, Arak University, Arak, Iran
2 shared publicationsMohammad Hadi Abbasian
Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran
2 shared publications
Latest Publications
- 3 November 2026
- Published by Wiley in Journal of Applied Toxicology
From Pesticide Exposure to Persistent Molecular Damage: An Integrated Framework of Genomic Instability, Epigenetic Dysregulation, and Long‐Term Toxicity
Pesticide toxicity is increasingly recognized as a chronic and mechanistically complex process extending beyond acute tissue injury. Evidence concerning cellular stress, genotoxicity, epigenetic alterations, susceptibility, and mixture effects has often been evaluated separately, limiting unified interpretation of persistent biological consequences. This review integrates experimental, epidemiological, and mechanistic evidence using an adverse outcome pathway (AOP)‐informed framework to organize pesticide‐associated molecular initiating events (MIEs), key events (KEs), key event relationships (KERs), and adverse outcomes (AOs), while distinguishing established AOPs from mechanistically plausible AOP‐informed modules. We examine interconnected oxidative, mitochondrial, calcium, endoplasmic reticulum, genomic, and epigenetic responses, with particular emphasis on bidirectional crosstalk between mitochondrial metabolism, redox signaling, and epigenetic regulation. Genetic susceptibility and combined pesticide exposure are also considered as modifiers of these relationships and of the persistence and biological significance of molecular changes. Particular attention is given to transient epigenetic responses, persistent epigenetic alterations, intergenerational effects, and true transgenerational inheritance, for which human evidence remains limited. Rather than assuming a single linear pathway, the review highlights convergent and branching relationships in which different pesticide classes may initiate distinct molecular events affecting overlapping downstream KEs. Molecular associations are not considered evidence of causal KERs without appropriate support from biological plausibility, temporal and dose–response concordance, mechanistic evidence, essentiality, and applicability. The review further considers how multi‐omics approaches, including MOFA/MOFA+, mixOmics, weighted gene co‐expression network analysis (WGCNA), and relevant toxicology/data resources, together with exposure assessment, chemical grouping, read‐across, and cumulative‐risk approaches, can provide complementary evidence within an AOP‐informed framework. The contribution of this review lies primarily in integrating and organizing existing evidence rather than proposing a new toxicological mechanism, AOP, or regulatory framework. Future toxicological strategies should integrate longitudinal evidence, susceptibility factors, exposure mixtures, and quantitative dose–response information to evaluate candidate KEs, their relationships, and relevance to AOs.
- 3 November 2026
- Published by Wiley in Journal of Applied Toxicology
From Pesticide Exposure to Persistent Molecular Damage: An Integrated Framework of Genomic Instability, Epigenetic Dysregulation, and Long‐Term Toxicity
Pesticide toxicity is increasingly recognized as a chronic and mechanistically complex process extending beyond acute tissue injury. Evidence concerning cellular stress, genotoxicity, epigenetic alterations, susceptibility, and mixture effects has often been evaluated separately, limiting unified interpretation of persistent biological consequences. This review integrates experimental, epidemiological, and mechanistic evidence using an adverse outcome pathway (AOP)‐informed framework to organize pesticide‐associated molecular initiating events (MIEs), key events (KEs), key event relationships (KERs), and adverse outcomes (AOs), while distinguishing established AOPs from mechanistically plausible AOP‐informed modules. We examine interconnected oxidative, mitochondrial, calcium, endoplasmic reticulum, genomic, and epigenetic responses, with particular emphasis on bidirectional crosstalk between mitochondrial metabolism, redox signaling, and epigenetic regulation. Genetic susceptibility and combined pesticide exposure are also considered as modifiers of these relationships and of the persistence and biological significance of molecular changes. Particular attention is given to transient epigenetic responses, persistent epigenetic alterations, intergenerational effects, and true transgenerational inheritance, for which human evidence remains limited. Rather than assuming a single linear pathway, the review highlights convergent and branching relationships in which different pesticide classes may initiate distinct molecular events affecting overlapping downstream KEs. Molecular associations are not considered evidence of causal KERs without appropriate support from biological plausibility, temporal and dose–response concordance, mechanistic evidence, essentiality, and applicability. The review further considers how multi‐omics approaches, including MOFA/MOFA+, mixOmics, weighted gene co‐expression network analysis (WGCNA), and relevant toxicology/data resources, together with exposure assessment, chemical grouping, read‐across, and cumulative‐risk approaches, can provide complementary evidence within an AOP‐informed framework. The contribution of this review lies primarily in integrating and organizing existing evidence rather than proposing a new toxicological mechanism, AOP, or regulatory framework. Future toxicological strategies should integrate longitudinal evidence, susceptibility factors, exposure mixtures, and quantitative dose–response information to evaluate candidate KEs, their relationships, and relevance to AOs.
- 5 September 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1542
Metal nanoparticles as next-generation therapeutics against antimicrobial resistance: mechanisms, functionalization, and translational potential
- 5 September 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1542
Metal nanoparticles as next-generation therapeutics against antimicrobial resistance: mechanisms, functionalization, and translational potential
- Open Access
- 8 April 2026
- Published by Elsevier in Journal of Hazardous Materials Advances
- Vol. 22
Metagenomics analysis of antibiotic resistance gene Co-selection by heavy metals and BTEX in landfill soils
- 8 April 2026
- Published by Elsevier in Journal of Hazardous Materials Advances
- Vol. 22
Open AccessMetagenomics analysis of antibiotic resistance gene Co-selection by heavy metals and BTEX in landfill soils
- 1 September 2025
- Published by Springer Nature in Biological Trace Element Research
- p. 1-9
Bismuth Oxide Nanoparticles-Induced Subclinical Nephrotoxicity in Male Mice: Role of Oxidative Stress and Apoptosis
Bismuth's unique properties have led to its widespread use in medical, cosmetic, and electronic applications. However, increasing evidence suggests potential toxicity, particularly from nanoparticle forms that may accumulate in organs. This study investigated the nephrotoxic effects of bismuth oxide nanoparticles (Bi₂O₃ NPs) in male NMRI mice, focusing on underlying molecular mechanisms. Adult mice were divided into control and experimental groups receiving 25–800 mg/kg Bi₂O₃ NPs via oral gavage for 30 days. Kidney function was assessed through serum urea and creatinine measurements. Gene expression analysis evaluated apoptosis markers (Bcl2, Bax, Casp3) and oxidative stress pathways (Nrf2, Hmox1) using RT-PCR. Histopathological examination assessed renal tissue alterations. Results revealed no significant changes in serum urea or creatinine levels. Molecular analysis revealed significant gene alterations: Bax (5.969-fold, p = 0.008) and Casp3 (5.568-fold, p = 0.007) upregulation, alongside Bcl2 downregulation (0.239-fold, p = 0.039), indicating apoptosis. Nrf2 (9.569-fold, p = 0.002) and Hmox1 (4.993-fold, p = 0.039) induction confirmed oxidative stress. Data demonstrate Bi₂O₃ NPs trigger apoptosis and oxidative stress. Histological examination revealed glomerular volume increased to 4.79 ± 0.22 mm3 (800 mg/kg/day, 44% higher than control, p < 0.001) without widespread structural damage. These findings indicate that while Bi₂O₃ NPs do not acutely impair kidney function, they induce cellular-level toxicity through apoptosis and oxidative stress pathways. The compensatory upregulation of antioxidant genes (Nrf2, Hmox1) suggests activation of protective mechanisms. Glomerular hypertrophy may represent an adaptive response to nanoparticle exposure. This study demonstrates that Bi₂O₃ NPs can cause subclinical nephrotoxicity through molecular mechanisms before functional impairment becomes apparent, underscoring the need for further investigation into long-term impacts and threshold doses.
- 1 September 2025
- Published by Springer Nature in Biological Trace Element Research
- p. 1-9
Bismuth Oxide Nanoparticles-Induced Subclinical Nephrotoxicity in Male Mice: Role of Oxidative Stress and Apoptosis
Bismuth's unique properties have led to its widespread use in medical, cosmetic, and electronic applications. However, increasing evidence suggests potential toxicity, particularly from nanoparticle forms that may accumulate in organs. This study investigated the nephrotoxic effects of bismuth oxide nanoparticles (Bi₂O₃ NPs) in male NMRI mice, focusing on underlying molecular mechanisms. Adult mice were divided into control and experimental groups receiving 25–800 mg/kg Bi₂O₃ NPs via oral gavage for 30 days. Kidney function was assessed through serum urea and creatinine measurements. Gene expression analysis evaluated apoptosis markers (Bcl2, Bax, Casp3) and oxidative stress pathways (Nrf2, Hmox1) using RT-PCR. Histopathological examination assessed renal tissue alterations. Results revealed no significant changes in serum urea or creatinine levels. Molecular analysis revealed significant gene alterations: Bax (5.969-fold, p = 0.008) and Casp3 (5.568-fold, p = 0.007) upregulation, alongside Bcl2 downregulation (0.239-fold, p = 0.039), indicating apoptosis. Nrf2 (9.569-fold, p = 0.002) and Hmox1 (4.993-fold, p = 0.039) induction confirmed oxidative stress. Data demonstrate Bi₂O₃ NPs trigger apoptosis and oxidative stress. Histological examination revealed glomerular volume increased to 4.79 ± 0.22 mm3 (800 mg/kg/day, 44% higher than control, p < 0.001) without widespread structural damage. These findings indicate that while Bi₂O₃ NPs do not acutely impair kidney function, they induce cellular-level toxicity through apoptosis and oxidative stress pathways. The compensatory upregulation of antioxidant genes (Nrf2, Hmox1) suggests activation of protective mechanisms. Glomerular hypertrophy may represent an adaptive response to nanoparticle exposure. This study demonstrates that Bi₂O₃ NPs can cause subclinical nephrotoxicity through molecular mechanisms before functional impairment becomes apparent, underscoring the need for further investigation into long-term impacts and threshold doses.
- 18 August 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-5
Xia-Gibbs syndrome in an 18-Year-Old Iranian girl: a case study of clinical features and genetic mutation
Background Xia-Gibbs syndrome (XGS) is a rare, autosomal dominant genetic disorder characterized by a broad spectrum of neurological, motor, and developmental symptoms. Case summary This study presents the first reported case of XGS in Iran involving an 18-year-old girl with diverse clinical manifestations, including developmental delay, motor disorders, delayed puberty, and behavioral disturbances. Genetic analysis identified a de novo nonsense mutation in the AHDC1 gene (c.2062 C > T, p.(Arg688Ter)), resulting in a truncated and non-functional protein, which correlates with the patient’s symptoms. Conclusion This case underscores the importance of early and accurate diagnosis of XGS and highlights the need for increased awareness among healthcare professionals, particularly in rare genetic disorders. Reporting such cases is crucial for enhancing understanding of the disease mechanisms and improving patient management.
- 18 August 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-5
Xia-Gibbs syndrome in an 18-Year-Old Iranian girl: a case study of clinical features and genetic mutation
Background Xia-Gibbs syndrome (XGS) is a rare, autosomal dominant genetic disorder characterized by a broad spectrum of neurological, motor, and developmental symptoms. Case summary This study presents the first reported case of XGS in Iran involving an 18-year-old girl with diverse clinical manifestations, including developmental delay, motor disorders, delayed puberty, and behavioral disturbances. Genetic analysis identified a de novo nonsense mutation in the AHDC1 gene (c.2062 C > T, p.(Arg688Ter)), resulting in a truncated and non-functional protein, which correlates with the patient’s symptoms. Conclusion This case underscores the importance of early and accurate diagnosis of XGS and highlights the need for increased awareness among healthcare professionals, particularly in rare genetic disorders. Reporting such cases is crucial for enhancing understanding of the disease mechanisms and improving patient management.
- 13 June 2025
- Published by Elsevier in Environmental Pollution
- Vol. 382, 126663
Metagenomic insights into bacterial communities and antibiotic resistance genes in landfill-impacted waters
- 13 June 2025
- Published by Elsevier in Environmental Pollution
- Vol. 382, 126663
Metagenomic insights into bacterial communities and antibiotic resistance genes in landfill-impacted waters
- 23 April 2025
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (2) , 1765-1785
Association of Spexin Gene Polymorphisms with Serum Spexin Levels and Biochemical Parameters in Iraqi Women with Type 2 Diabetes Mellitus: A Case–Control Study
Diabetes mellitus, particularly Type 2 diabetes mellitus (T2DM), is a prevalent metabolic disorder with significant health implications. This study aimed to investigate the association between spexin (SPX) gene polymorphisms and serum Spexin levels in Iraqi women with T2DM. A case–control study was conducted involving 100 diabetic patients and 100 healthy controls, with data collected on biochemical parameters such as fasting blood sugar (FBS), body mass index (BMI), and lipid profiles. Genomic DNA was extracted, and Sanger sequencing was performed to identify SNPs in the SPX gene. Significant differences in BMI, FBS, LDL, and Spexin levels were observed between the T2DM and control groups (p < 0.05). Among the analyzed SNPs, rs761986956 showed a significant association with T2DM, where the G allele increased susceptibility (p 0.04, OR 2.62, 95% CI 1–6.8). Additionally, rs1214680179 exhibited a borderline association with T2DM (p 0.05) and was linked to lower serum Spexin concentrations, suggesting a possible role in metabolic regulation. In contrast, rs780278792, rs1413328860, and rs772766676 showed no significant association with T2DM susceptibility (p > 0.05). These findings suggest that rs761986956 and potentially rs1214680179 may contribute to T2DM pathogenesis, emphasizing the role of genetic factors in disease development. Furthermore, they highlight the importance of studying SPX gene polymorphisms as potential biomarkers for diabetes management in the Iraqi population. Given the preliminary nature of some associations, further research with larger, more diverse cohorts is needed to validate these findings and clarify their biological implications.
- 23 April 2025
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (2) , 1765-1785
Association of Spexin Gene Polymorphisms with Serum Spexin Levels and Biochemical Parameters in Iraqi Women with Type 2 Diabetes Mellitus: A Case–Control Study
Diabetes mellitus, particularly Type 2 diabetes mellitus (T2DM), is a prevalent metabolic disorder with significant health implications. This study aimed to investigate the association between spexin (SPX) gene polymorphisms and serum Spexin levels in Iraqi women with T2DM. A case–control study was conducted involving 100 diabetic patients and 100 healthy controls, with data collected on biochemical parameters such as fasting blood sugar (FBS), body mass index (BMI), and lipid profiles. Genomic DNA was extracted, and Sanger sequencing was performed to identify SNPs in the SPX gene. Significant differences in BMI, FBS, LDL, and Spexin levels were observed between the T2DM and control groups (p < 0.05). Among the analyzed SNPs, rs761986956 showed a significant association with T2DM, where the G allele increased susceptibility (p 0.04, OR 2.62, 95% CI 1–6.8). Additionally, rs1214680179 exhibited a borderline association with T2DM (p 0.05) and was linked to lower serum Spexin concentrations, suggesting a possible role in metabolic regulation. In contrast, rs780278792, rs1413328860, and rs772766676 showed no significant association with T2DM susceptibility (p > 0.05). These findings suggest that rs761986956 and potentially rs1214680179 may contribute to T2DM pathogenesis, emphasizing the role of genetic factors in disease development. Furthermore, they highlight the importance of studying SPX gene polymorphisms as potential biomarkers for diabetes management in the Iraqi population. Given the preliminary nature of some associations, further research with larger, more diverse cohorts is needed to validate these findings and clarify their biological implications.
- 26 February 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 203 (10) , 5245-5261
Investigating the Impact of Bismuth Oxide Nanoparticles on Dazl Gene Expression and Spermatogenesis Indices in Male Mice
Bismuth (Bi) exposure has been linked to various health effects, but its direct impact on male fertility remains largely unexplored. This study investigated the effects of bismuth oxide nanoparticles (Bi₂O₃ NPs) on male reproductive function in Naval Medical Research Institute (NMRI) mice. The mice were randomly allocated to seven groups: one control receiving physiological saline and six treatment groups receiving Bi₂O₃ NPs (25, 50, 100, 200, 400, and 800 mg/kg body weight/day) for 35 days. Treatment was administered via oral gavage. Following treatment, we evaluated body weight, blood serum biochemistry, Dazl gene expression, sperm quality, testicular histology, and cell counts (spermatogenic, Leydig, and Sertoli cells). Compared with the control, Bi₂O₃ NPs exposure resulted in significant reductions in testosterone levels, total antioxidant capacity, superoxide dismutase activity, Dazl gene expression, sperm motility, count, viability, normal morphology, and DNA integrity, and the level of malondialdehyde (MDA) increased. Additionally, testicular tissue and seminiferous tubule volume decreased, whereas interstitial tissue volume increased. Notably, sperm production was impaired, as evidenced by reduced numbers of spermatogonia, spermatocytes, spermatids, Sertoli cells, and Leydig cells. Body weight and seminiferous tubule basement membrane parameters remained largely unaffected. These findings suggest that Bi₂O₃ NPs induce oxidative stress, leading to lipid peroxidation and ultimately compromising male fertility. Our study highlights the potential detrimental effects of Bi₂O₃ NPs exposure on male reproductive health and warrants further investigation into their impact on human fertility at relevant concentrations.
- 26 February 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 203 (10) , 5245-5261
Investigating the Impact of Bismuth Oxide Nanoparticles on Dazl Gene Expression and Spermatogenesis Indices in Male Mice
Bismuth (Bi) exposure has been linked to various health effects, but its direct impact on male fertility remains largely unexplored. This study investigated the effects of bismuth oxide nanoparticles (Bi₂O₃ NPs) on male reproductive function in Naval Medical Research Institute (NMRI) mice. The mice were randomly allocated to seven groups: one control receiving physiological saline and six treatment groups receiving Bi₂O₃ NPs (25, 50, 100, 200, 400, and 800 mg/kg body weight/day) for 35 days. Treatment was administered via oral gavage. Following treatment, we evaluated body weight, blood serum biochemistry, Dazl gene expression, sperm quality, testicular histology, and cell counts (spermatogenic, Leydig, and Sertoli cells). Compared with the control, Bi₂O₃ NPs exposure resulted in significant reductions in testosterone levels, total antioxidant capacity, superoxide dismutase activity, Dazl gene expression, sperm motility, count, viability, normal morphology, and DNA integrity, and the level of malondialdehyde (MDA) increased. Additionally, testicular tissue and seminiferous tubule volume decreased, whereas interstitial tissue volume increased. Notably, sperm production was impaired, as evidenced by reduced numbers of spermatogonia, spermatocytes, spermatids, Sertoli cells, and Leydig cells. Body weight and seminiferous tubule basement membrane parameters remained largely unaffected. These findings suggest that Bi₂O₃ NPs induce oxidative stress, leading to lipid peroxidation and ultimately compromising male fertility. Our study highlights the potential detrimental effects of Bi₂O₃ NPs exposure on male reproductive health and warrants further investigation into their impact on human fertility at relevant concentrations.
- Open Access
- 24 December 2024
- Published by Brieflands in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 15 (4)
From the Shadow of Virus Infection to Darkness of the Diabetes
: The global surge in diabetes presents a significant healthcare challenge. Viral infections complicate diabetes by influencing systemic metabolism and disrupting glycemic control in type 2 diabetes (T2D). High glucose levels impair macrophage activity, raising the risk of chronic infections. Viral-induced type-I immune responses initiate insulin resistance, which affects muscle, liver, and pancreatic functions. Diabetogenic viruses impair pancreatic cells or affect gut microbiota. Viral survival tactics disrupt antigen presentation and use viral miRNAs to target diabetes-related gene expression. The hidden association between latent viruses, particularly herpesviruses like Human Cytomegalovirus (HCMV), and diabetes is explored, emphasizing CMV's role in type 1 diabetes (T1D) pathogenesis. Inflammatory pathways triggered by viral infections play a critical role in islet-specific autoimmunity and the development of T1D. The HCMV’s pervasive reach, from local areas to the entire body, involves infected monocytes infiltrating organs, persisting in the bone marrow, and enabling virus spread during reactivation events. When a viral infection occurs, the immune system mounts a type 1 response characterized by the activation of CD4+ T-cells and the production of pro-inflammatory cytokines, such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α). These cytokines can lead to the recruitment of immune cells to pancreatic islets, resulting in inflammation and damage to insulin-producing beta cells. Furthermore, the chronic inflammation caused by sustained cytokine release can impair insulin signaling pathways. Specifically, pro-inflammatory cytokines interfere with insulin receptor substrate (IRS) proteins, leading to decreased insulin sensitivity in peripheral tissues such as muscle and adipose tissue. This cascade of events ultimately contributes to the development of insulin resistance, setting the stage for T2D. This investigation highlights the complex relationship between viral infections and diabetes. Research indicates that viral infections can increase the risk of developing T2D.
- 24 December 2024
- Published by Brieflands in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 15 (4)
Open AccessFrom the Shadow of Virus Infection to Darkness of the Diabetes
: The global surge in diabetes presents a significant healthcare challenge. Viral infections complicate diabetes by influencing systemic metabolism and disrupting glycemic control in type 2 diabetes (T2D). High glucose levels impair macrophage activity, raising the risk of chronic infections. Viral-induced type-I immune responses initiate insulin resistance, which affects muscle, liver, and pancreatic functions. Diabetogenic viruses impair pancreatic cells or affect gut microbiota. Viral survival tactics disrupt antigen presentation and use viral miRNAs to target diabetes-related gene expression. The hidden association between latent viruses, particularly herpesviruses like Human Cytomegalovirus (HCMV), and diabetes is explored, emphasizing CMV's role in type 1 diabetes (T1D) pathogenesis. Inflammatory pathways triggered by viral infections play a critical role in islet-specific autoimmunity and the development of T1D. The HCMV’s pervasive reach, from local areas to the entire body, involves infected monocytes infiltrating organs, persisting in the bone marrow, and enabling virus spread during reactivation events. When a viral infection occurs, the immune system mounts a type 1 response characterized by the activation of CD4+ T-cells and the production of pro-inflammatory cytokines, such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α). These cytokines can lead to the recruitment of immune cells to pancreatic islets, resulting in inflammation and damage to insulin-producing beta cells. Furthermore, the chronic inflammation caused by sustained cytokine release can impair insulin signaling pathways. Specifically, pro-inflammatory cytokines interfere with insulin receptor substrate (IRS) proteins, leading to decreased insulin sensitivity in peripheral tissues such as muscle and adipose tissue. This cascade of events ultimately contributes to the development of insulin resistance, setting the stage for T2D. This investigation highlights the complex relationship between viral infections and diabetes. Research indicates that viral infections can increase the risk of developing T2D.